Identification of tumor vascular antigens by monoclonal antibodies prepared from rat-tumor-derived endothelial cells

International Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 561-566

  Ohizumi, Iwao ^a   Tsunoda, Shin Ichi ^b   Taniguchi, Kenji ^a   Saito, Hiroyuki ^a   Esaki, Keiko ^a   Koizumi, Keiichi ^b   Makimoto, Hiroo ^b   Wakai, Yukiko ^b   Matsui, Junji ^b   Tsutsumi, Yasuo ^b   Nakagawa, Shinsaku ^b   Utoguchi, Naoki ^c   Ohsugi, Yoshiyuki ^a   Mayumi, Tadanori ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CELL ISOLATION; ENDOTHELIUM CELL; EPIDIDYMIS FAT; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MEMBRANE VESICLE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CAPILLARIES; CARCINOGENS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; HYBRIDOMAS; METHYLCHOLANTHRENE; MICE; MICE, INBRED BALB C; RATS;

EID: 0031872326     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980812)77:4<561::AID-IJC15>3.0.CO;2-9     Document Type: Article

References (29)

1. AUSPRUNK, D.H. and FOLKMAN, J., Migration and proliferation of endothelial cells in pre-formed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res., 14, 53-65 (1977).
2. BOEHM, T., FOLKMAN, J., BROWDER, T. and O'REILLY, M.S., Anti-angiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390, 404-407 (1997).
3. BURROWS, F.J., DERBYSHIRE, E.J., TAZZARI, P.L., AMLOT, P., GAZDAR, A.F., KING, S.W., LETARTE, M., VITETTA, E.S. and THORPE, P.E., Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin. Cancer Res., 1, 1623-1634 (1995).
4. FOLKMAN, J., Tumor angiogenesis. Advanc. Cancer Res., 43, 175-203 (1985).
5. FOLKMAN, J., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31 (1995).
6. FOLKMAN, J. and KLAGSBRUN, M., Angiogenic factors. Science, 235, 442-447 (1987).
7. FOLKMAN, J. and SHING, Y., Angiogenesis. J. biol Chem., 267, 10931-10934 (1992).
8. GOTOHDA, E., SENDO, F., NAKAYAMA, M., HOSOKAWA, M., KAWAMURA, T., KODAMA, T. and KOBAYASHI, H., Change of antigenic expression on rat tumor cells alter their transplantation. J. nat. Cancer Inst., 55, 1079-1083 (1975).
9. HANAHAN, D., A flanking attack on cancer. Nature Med., 4, 13-14 (1998).
10. HUANG, X., MOLEMA, G., KING, S., WATKINS, L., EDGINGTON, T.S. and THORPE, P.E., Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science, 275, 547-550 (1997).
11. INGBER, D., FUJITA, T., KISHIMOTO, S., SUDO, K., KANAMARU, T., BREM, H. and FOLKMAN, J., Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond.), 348, 555-557 (1990).
12. JAIN, R.K., Determinants of tumor blood flow: a review. Cancer Res., 48, 2641-2658 (1988).
13. KLAGSBRUN, N.M. and D'AMORE, P.A., Regulators of angiogenesis. Ann. Rev. Physiol., 53, 217-239 (1991).
14. MACCHIARINI, P., FONTANINI, G., HARDIN, M.J., SQUARTINI, F. and ANGELETTI, C.A., Relation of neovascularisation to metastasis of non-small-cell lungcancer. Lancet, 340, 145-146 (1992).
15. MAORI, J.A. and WILLIAMS, S.K., Capillary endothelial-cell cultures: phenotypic modulation by matrix components. J. Cell Biol., 97, 153-165 (1983).
16. MCCULLOCH, P., CHOY, A. and MARTIN, L., Association between tumour angiogenesis and tumour-cell shedding into effluent venous blood during breast-cancer surgery. Lancet, 346, 1334-1335 (1995).
17. OHE, Y., PODACK, E.R., OLSEN, K.J., MIYAHARA, Y., MIURA, K., SAITO, H., KOISHIHARA, Y., OHSUGI, Y., OHIRA, T., NISHIO, K. and SAIJO, N., Interleukin-6-cDNA-transfected Lewis-lung-carcinoma cells show unaltered net tumour-growth rate but cause weight loss and shorten survival in syngeneic mice. Brit. J. Cancer, 67, 939-944 (1993).
18. OHIZUMI, I. and 12 OTHERS, Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid-tumor growth in rats. Biochem. Biophys. Res. Commun., 236, 493-496 (1997).
19. O'REILLY, M.S., BOEHM, T., SHING, Y., FUKAI, N., VASIOS, G., LANE, W.S., FLYNN, E., BIRKHEAD, J.R., OLSEN, B.R. and FOLKMAN, J., Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285 (1997).
20. RETTIG, W.J., GARIN-CHESA, P., HEALEY, J.H., SU, S.L., JAFFE, E.A. and OLD, L.J., Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc. nat. Acad. Sci. (Wash.), 89, 10832-10836 (1992).
21. SCOTT, R.E., Plasma-membrane vesiculation: a new technique for isolation of plasma membranes. Science, 194, 743-745 (1976).
22. SEON, B.K., MATSUNO, F., HARUTA, Y., KONDO, M. and BARCOS, M., Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with anti-human endoglin immunotoxin. Clin. Cancer Res., 3, 1031-1044 (1997).
23. TEICHER, B.A., HOLDEN, S.A., ARA, G., SOTOMAYOR, E.A., HUANG, Z.D., CHEN, Y.N. and BREM, H., Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int. J. Cancer, 57, 920-925 (1994).
24. THALHAMER, J. and FREUND, J., Passive immunization: a method of enhancing the immune response against antigen mixtures. J. immunol. Meth., 80, 7-13 (1985).
25. UTOGUCHI, N., DANTAKEAN, A., MAKIMOTO, H., WAKAI, Y., TSUTSUMI, Y., NAKAGAWA, S. and MAYUMI, T., Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma. Jap. J. Cancer Res., 86, 193-201 (1995).
26. VIKKULA, M., BOON, L.M., CARRAWAY, K.L. 3RD., CALVERT, J.T., DIAMONTI, A.J., GOUMNEROV, B., PASYK, K.A., MARCHUK, D.A., WARMAN, M.L., CANTLEY, L.C., MULLIKEN, J.B. and OLSEN, B.R., Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell, 87, 1181-1190 (1996).
27. WANG, J.M., KUMAR. S., PYE, D., VAN AGTHOVEN, A.J., KRUPINSKI, J. and HUNTER, R.D., A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int. J. Cancer, 54, 363-370 (1993).
28. WEIDNER, N., CARROLL, P.R., FLAX, J., BLUMENFELD, W. and FOLKMAN, J., Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Amer. J. Pathol., 143, 401-409 (1993).
29. WEIDNER, N., SEMPLE, J.P., WELCH, W.R. and FOLKMAN, J., Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl. J. Med., 324, 1-8 (1991).